Kaushlya Medical And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 27 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.90 M
- Revenue Growth 11.30%
- Profit Growth -5.72%
- Ebitda 0.46%
- Net Worth 16.85%
- Total Assets 5.01%
About Kaushlya Medical And Research Centre
Kaushlya Medical And Research Centre Private Limited (KMARCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 January 1998 and has a history of 27 years. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Rahul Garg, Anisha Garg, and Kiran Garg serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110DL1998PTC091950
- Company No.
091950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kaushlya Medical And Research Centre?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rahul Garg | Director | 28-Jan-1998 | Current |
Anisha Garg | Director | 27-Aug-2020 | Current |
Kiran Garg | Director | 28-Jan-1998 | Current |
Financial Performance of Kaushlya Medical And Research Centre.
Kaushlya Medical And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.3% increase. The company also saw a slight decrease in profitability, with a 5.72% decrease in profit. The company's net worth Soared by an impressive increase of 16.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kaushlya Medical And Research Centre?
In 2020, Kaushlya Medical And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.90 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Dec 2014 | Bank Of Baroda | ₹0.90 M | Open |
How Many Employees Work at Kaushlya Medical And Research Centre?
Unlock and access historical data on people associated with Kaushlya Medical And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaushlya Medical And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaushlya Medical And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.